Business Model Breakdown
How CHEK Makes Money
CHEK
Market Cap
$13M
Annual Revenue
$5.2B
The Short Version
The original Check-Cap Ltd., which previously focused on developing a disposable capsule system for colorectal cancer screening, ceased to exist as an independent entity after its merger with Gataca Health Inc. in March 2023. The combined entity now operates under the ticker GTCA. Therefore, the CHEK ticker no longer represents an active business model or revenue streams.
Why It Works (Competitive Advantages)
- ✔N/A - Ticker is delisted.
Economic Moat: None
What Our Analysis Says
DVR Score as of April 15, 2026
Check-Cap Ltd. (CHEK) fundamentally ceased to exist as an independent growth vehicle following its merger with Gataca Health Inc. in March 2023. The combined entity now trades as GTCA, and the original CHEK ticker is delisted and no longer represents an active, tradable company with independent operations. The real-time market intelligence provided further corroborates this, showing 'no verifiable data' for Check-Cap Ltd. or any matching entity on requested metrics. Therefore, the likelihood of Check-Cap Ltd. achieving 10x growth as the specified entity is virtually zero due to its non-existence. Investing in CHEK as a standalone entity is impossible and would yield no return, classifying it as a complete dud. The score remains consistent with the previous assessment, as no material changes have occurred to alter its status.